Resultados de la búsqueda 31-40 of 2227 for ���������������������������op������r���:za33���

  1. Radiología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate the safety, pharmacokinetics and biodistribution of an imaging agent, 18F-OP-801 (18F Hydroxyl Dendrimer), ...

  2. Mayo Clinic Urology Physician Update — October 2025

    Page 1.

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

  4. Cirugía - Ensayos clínicos - Mayo Clinic

    ... operative hernia and operative complications. The Effects of Prophylactic Limited Palmar Fasciectomy on Surgical Outcomes and Scarring. Rochester, Minn ...

  5. Mayo Clinic Urology Physician Update — April 2025

    Page 1.

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by Phase 3), parallel ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) on ...

  9. Mayo Clinic Physician Update - March 2025

    Page 1.

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) on ...